Schizophrenia Genes Increase Chance of IQ Loss
News Feb 22, 2013
Scientists at the University of Edinburgh say the findings could lead to new research into how different genes for schizophrenia affect brain function over time. They also show that genes associated with schizophrenia influence people in other important ways besides causing the illness itself.
The researchers used the latest genetic analysis techniques to reach their conclusion on how thinking skills change with age.
They compared the IQ scores of more than 1,000 people from Edinburgh who were tested for general cognitive functions in 1947, when the subjects were aged 11, and again when they were around 70 years old.
The researchers were able to examine people's genes and calculate each subject's genetic likelihood of developing schizophrenia, even though none of the group had ever developed the illness.
They then compared the IQ scores of people with a high and low risk of developing schizophrenia. They found that there was no difference at age 11, but people with a greater genetic risk of schizophrenia had slightly lower IQs at age 70.
Those people who had more genes linked to schizophrenia also had a greater estimated fall in IQ over their lifetime than those at lower risk.
Ian Deary, Director of the University of Edinburgh's Centre for Cognitive Ageing and Cognitive Epidemiology, who led the research team, said: "Retaining our thinking skills as we grow older is important for living well and independently. If nature has loaded a person's genes towards schizophrenia, then there is a slight but detectable worsening in cognitive functions between childhood and old age."
Andrew McIntosh, of the University of Edinburgh's Centre for Clinical Brain Sciences, said: "With further research into how these genes affect the brain, it could become possible to understand how genes linked to schizophrenia affect people's cognitive functions as they age."
Schizophrenia - a severe mental disorder characterised by delusions and by hallucinations - is in part caused by genetic factors. It affects around 1 per cent of the population, often in the teenage or early adult years, and is associated with problems in mental ability and memory.
The study, which was funded by the Biotechnology and Biological sciences Research Council, Age UK, and the Chief Scientist Office, is published in the journal Biological Psychiatry.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE